CRVS
NASDAQ HealthcareCorvus Pharmaceuticals, Inc. - Common Stock
Biotechnology
📊 Market Data
| Price | $16.01 |
|---|---|
| Volume | 1,151,195 |
| Market Cap | 1.34B |
| Beta | 0.840 |
| RSI (14-Day) | 45.9 |
| 200-Day MA | $8.58 |
| 50-Day MA | $16.07 |
| 52-Week High | $26.95 |
| 52-Week Low | $2.54 |
| Forward P/E | -25.11 |
| Price / Book | 16.66 |
🎯 Investment Strategy Scores
How CRVS scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
37/100
High dividend yield + low volatility
🚀 Moon Shot
36/100
High growth potential (high beta + oversold)
🔪 Falling Knife
5/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
65/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
31/100
Large-cap, institutional-quality stocks
Find CRVS in your text
Paste any text on the homepage — the tool will extract CRVS and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.